Patently-O
AUGUST 22, 2022
For our patent law course today, the students read the Justice O’Connor unanimous opinion in Bonito Boats, Inc. Bonito Boats centers on a Florida statute prohibiting copying of unpatented boat hulls via direct molding. The Florida courts had refused to enforce the law because it conflicted with Federal Patent Law.
Patently-O
AUGUST 13, 2021
The 1836 Patent Act added the caveat that no patent should issue on an invention previously “described in any printed publication.” ” That language has carried through the various major patent law overhauls and continues as a prominent aspect of 35 U.S.C. by Dennis Crouch. 102(a)(1). 869, 877 (Fed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Biswajit Sarkar Copyright Blog
OCTOBER 22, 2021
Patent opposition, if used properly, is an important tool to prevent the grant of frivolous patents. However, this raises question of the misuse of opposition to prevent patents with great competitive value thereby affecting the business of competitors. Types of Patent Opposition in India.
Garrigues Blog
JANUARY 12, 2022
The owner of a patent cannot enforce their rights against those who used the invention covered by the patent or made serious preparations for such use before the priority date. What is the right of prior use or “pre-use”? What prerogatives does the right to prior use grant?
Patently-O
APRIL 6, 2023
A key feature of the SAS product is that folks can write programs using SAS syntax in order to get certain results. WPL is a UK based software company who obtained several copies of SAS statistical software and made their own clone version by rewriting the code and by relying upon an early version of SAS that is not protected by copyright.
LexBlog IP
OCTOBER 24, 2022
However, if the Contractor fails to report any inventions to the contracting officer within two months of preparing the corresponding patent applications, the Contractor risks losing ownership of those inventions. The nations in which the Contractor seeks to file the patent application. media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-63579507143ea2268{display:
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
Manufacturers of Enbrel ® biosimilars (Sandoz and Samsung Bioepis) have been embroiled in patent litigation with Immunex, and, as discussed below, Sandoz recently lost its appeal to the Federal Circuit. All currently approved Humira ® biosimilars cannot launch until 2023 per settlements with AbbVie. FDA Addresses the COVID-19 Global Pandemic.
Expert insights. Personalized for you.
90 
Let's personalize your content